Immunotherapy with CD19zeta gene-modified EBV-specific CTLs after stem cell transplant in children with high-risk acute lymphobiastic leukemia (CD19TPALL)
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/01/2013 - 31/12/2015